ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Studies in both humans and animals show that circulatory adiponectin levels are negatively correlated with various pathological conditions including CVDs, T2DM, obesity, insulin resistance, NAFLD, atherosclerosis, cardiomyopathy and HF [117].